How we approach patient evaluation for hematopoietic stem cell transplantation
Family donor care management: principles and recommendations
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital
Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia
Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome
Hematopoietic SCT in children with Griscelli syndrome: a single-center experience
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia
Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT
HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome
Differential chemokine expression in chronic GVHD of the conjunctiva
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring
Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series
Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma
Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation
Allo-SCT in a rare t(8;21) evolution of CML
Plerixafor and pegylated filgrastim: a case of safe and effective hematopoietic stem cell mobilization
Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning
T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation
Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center
Occult autologous haematopoietic regeneration without disease relapse following myeloablative allogeneic haematopoietic SCT for lymphomas